| FDA | Food and Drug Administration |
| AM | Additive manufacturing |
| SLS | Selective laser sintering |
| SLA | Stereolithography |
| FDM | Fused deposition modeling |
| ROS | Reactive oxygen species |
| DIC | Digital image correlation |
| GAG | Glycosaminoglycans |
| LCST | Lower critical solution temperature |
| UCST | Upper critical solution temperature |
| CS | Chitosan |
| CAD | Computer-aided design |
| HME | Hot melt extrusion |
| API | Active pharmaceutical ingredients |
| PAM | Pressure-assisted microsyringe |
| NMMO | N-methylmorpholine-N-oxide monohydrate |
| MBA | N, N′-methylene bisacrylamide |
| HA | Hyaluronic acid |
| ADA-GEL-PPy | Gelatin-content oxidized alginate-gelatin polypyrrole |
| L-PRF | Lyophilized platelet-rich fibrin |
| HAP | Hydroxyapatite |
| CN+HAMA | Cellulose nanofibers and hyaluronic acid methacrylate |
| PCL | Polycaprolactone |
| PDA | Polydopamine |
| CFZ | Cefazolin |
| RFP | Rifampicin |
| CNFs | Cellulose nanofibers |
| PHB/PCL | Poly-hydroxybutyrate/poly(ε-caprolactone) |
| OKGM/PEI | Oxidized konjac glucomannan/polyethyleneimine |
| CNTs | Carbon nanotubes |
| TFNA | Tetrahedral framework nucleic acid |
| SMSCs | Synovial mesenchymal stem cells |
| AC | Articular cartilage |
| pNPP | p-nitrophenyl phosphate |
| VEGF | Vascular Endothelial Growth Factor |
| OHA | Oxidized hyaluronate |
| GC | Glycol chitosan |
| ADH | Adipic acid dihydrazide |
| hBMSCs | Human Bone Marrow Mesenchymal Stem Cell |
| MHBC | Methacrylated Hydroxylbutyl Chitosan |
| GO | Graphene oxide |
| GEL | Gelatin |
| ALG | Alginate |
| NFC | Fibrillated cellulose |
| CMC | Carboxymethyl cellulose |
| TS | Tensile strength |
| CS | Compressive strength |
| FS | Flexural strength |
| CLPs | Colloidal lignin particles |
| DCM | Dichloromethane |
| 2-Bu | 2-butoxy ethanol |
| DBP | Dibutyl phthalate |
| PLLA | Poly(L-lactide) |
| CHWs | Chitin whiskers |
| DIW | Direct ink writing |
| CP | CHWs/PLLA |
| TOCNFs | (2,2,6,6-tetramethylpiperidine-1-oxylradi-cal)-mediated oxidized cellulose nano-fibrils |